White Paper Available! Telehealth Solutions Enhance Health Outcomes and Reduce Healthcare Costs

White paper: Can we enhance health outcomes with telehealth?

There is intense pressure for the life sciences industry to demonstrate that treatments enhance health outcomes and decrease healthcare costs. Life science companies need tools to track patient outcomes, and gather data that demonstrates the impact a treatment has on health outcomes.

Telehealth solutions can be customized to gather patient vital signs and interview data based on the patient’s health condition. This information can be used in many ways to enhance health outcomes and reduce costs.

This white paper provides an overview of what telehealth is, factors driving the healthcare industry to focus on increasing outcomes and reducing costs, how telehealth solutions can enhance health outcomes and reduce costs, benefits life science companies can expect from telehealth solutions, as well as share results from two key studies of telehealth solutions.

If you’d like a copy of the white paper titled “Telehealth Solutions Enhance Health Outcomes and Reduce Healthcare Costs”, please click to request it. I’d love to hear what you think of this latest white paper—is it helpful or not? Also, please share with me areas you’d like to see more information and recommendations on.

Wanted: Technologies that Empower Patients

Dr. Cafazzo talks about empowering patients

Inspiring TEDxToronto talk provides examples of technologies that engage patients and help them live well.

I ran across an inspiring presentation by Dr. Joseph Cafazzo on the intersection of patients, healthcare providers, hospitals, and technology to empower patients to live better lives. This presentation was part of the recent TEDxToronto meeting. Dr. Cafazzo is the Lead for the Centre for Global eHealth Innovation, a state-of-the-art research facility devoted to the evaluation and design of healthcare technology in Toronto, Canada.

In the presentation Dr. Cafazzo shares that 75% of healthcare spending is spent treating seven conditions including…

* Diabetes
* Kidney disease
* High blood pressure
* Heart failure
* Lung disease
* Mental health
* Cancer

In most cases these are chronic conditions that need to be managed over a period of time. With appropriate care and adherence to medication, healthcare spending on these conditions can be decreased and patients can live well. For this to take place healthcare providers and hospitals need patients that are engaged and empowered to manage their health.

Dr. Cafazzo is a leading researcher on the use of technology to facilitate patient self-care of complex chronic conditions. In the video he shares several technologies that have made a significant impact to empower patients to manage their condition(s).

We live in exciting times where technology is stimulating monumental progress. Many new technologies are available to help patients be engaged and empowered to manage their health. Effective solutions are needed, and patients need options so they can select the tools that meet their needs and preferences from mobile health sites, app-based health management tools, telehealth devices, educational websites, to nurse educator programs that provide 24/7 assistance to answer patient questions.

At Tunstall AMAC we are focused on helping build and maintain relationships with patients, caregivers, and healthcare providers to drive awareness and knowledge, support patient adherence, and empower patients to take charge of their health. We offer a wide-variety of personal emergency response and telehealth devices that can be used in the home-setting, and we provide 24/7 monitoring and click-to-chat support services to provide support, information, and educational materials to patients, providers, and payers.

I’d like to hear your thoughts on the use of technology to engage patients and empower them to manage their health. Have you, or your company, used these technologies? If so, please share your insights and experiences.

Look to the Future: Physicians Recommend Mobile Apps

Apps for Health Management

Early-adopting physicians recommend mobile apps to enhance patient compliance and outcomes

There is evidence that adults in the US are using cell phones and smartphones to manage their health, and use is growing at a moderate pace. A recent blog post shared results from the Mobile Health 2012 survey, which was published by The Pew Internet and American Life Project. The findings from this survey offer significant insights into how US consumers use their cell phones and smartphones to access health information and health apps. Two key findings that jumped out to me are…

* 31% of cell phone users use their phone to search for health information (in 2010 it was only 17%)

* 19% of smartphone owners have at least one health app on their phone. Exercise, diet, and weight apps are the most popular

As the healthcare industry shifts to outcomes-based payment models, healthcare providers and payers will look for effective and economical ways to help patients better manage their health. Increasing patient adherence to treatment is a primary area that healthcare providers and payers are interested in impacting.

Recently, a post titled “When the Rx is an App” was published on the American Medical News blog (which is published by the American Medical Association). This post focuses on forward-thinking physicians recommending apps to help patients manage their condition, track medication adherence, and monitor their symptoms and vital signs. There are no definitive numbers on how many physicians recommend apps to their patients, but no doubt there is opportunity for apps as a part of a comprehensive patient adherence program. App-based health management tools are convenient and the learning curve for many patients is minimal. Patients carry their smartphones with them and are in the habit of using their smartphones to access e-mail, apps, and search for information.

As the life science industry continues to focus on patient outcomes, with an emphasis on adherence and compliance, there are opportunities for life science companies to provide significant value to patients, healthcare providers, and payers. App-based health management tools are just one component of a potential solution. Effective solutions will include various components so patients can select the tools they are most comfortable with including mobile health sites, telehealth devices, educational websites, and nurse educator programs that provide 24/7 assistance to answer patient questions.

Currently, there are apps that collect patient information such as heart rate, weight, calories burned, calories consumed, etc. that can be shared with healthcare providers during office visits. In the future, technologies such as telehealth devices and apps will summarize collected patient information, send it to healthcare providers, and upload the information directly into electronic health records. With these advances healthcare providers receive accurate patient-specific information that can be used to guide treatment discussions and decisions.

At Tunstall AMAC we are focused on helping build and maintain relationships with patients, caregivers, and healthcare providers to drive awareness and knowledge, support patient adherence, and empower patients to take charge of their health. We offer a wide-variety of personal emergency response and telehealth devices that can be used in the home-setting, and we provide 24/7 monitoring and click-to-chat support services to provide support, information, and educational materials to patients, providers, and payers.

I’d like to hear your thoughts on the use of apps to manage an individual’s health. Do you use healthcare-related apps? Is your company providing these services now? Is your company likely to provide them in the future? Please share your questions and comments, and let’s all learn from each other.

Smartphones: Fertile Ground for Health Information

Interesting stats on smartphone usage - more below

Pew Internet and American Life Project finds half of smartphone owners use their devices to get health information.

The Pew Internet and American Life Project recently published results from the Mobile Health 2012 survey. The findings from this survey offer significant insights into how US consumers use their smartphones to access health information and health apps. These findings are evidence that life science companies have significant opportunities to provide value-added services and products that help patients improve their health.

Key findings from the Mobile Health 2012 survey include…

* 85% of US adults own a cell phone
  - 53% are smartphones

* 31% of cell phone users use their phone to search for health information
  - In 2010 only 17% of cell phone users used their phones to search for health information
  - 52% of smartphone owners access health information via their smartphone

* 19% of smartphone owners have at least one health app on their phone
  - Exercise, diet, and weight apps are the most popular

* 9% of cell phone owners receive text updates and alerts about their health or medical issues
  - 80% of cell phone owners send and receive text messages

*  Those most likely to have signed up for health text alerts...
  - Women between the ages of 30 and 64
  - Smartphone owners

* Those most likely to use cell phones to search for health information…
  - Caregivers
  - Those who recently faced a medical crisis
  - Those who recently experienced a significant change in their physical health

Clearly adults in the US are more often using their cell phones and smartphones to manage their health, and use is growing at a moderate pace. As the life science industry continues to focus on patient outcomes, with an emphasis on adherence and compliance, there are opportunities for life science companies to provide mobile healthcare apps and services that provide significant value to patients, healthcare providers, and payers.

Key areas to consider when planning mobile health initiatives …

Mobile health sites and apps can have a significant impact; however, these are just two components of a potential solution. There are new technologies, such as telehealth devices that are powerful tools or capturing and sharing information between patients and healthcare providers. Additionally, don’t overlook the importance of educational websites and nurse educator programs that provide 24/7 assistance to answer patient questions.

At Tunstall AMAC we are focused on helping build and maintain relationships with patients, caregivers, and healthcare providers to drive awareness and knowledge, support patient adherence, and empower patients to take charge of their health. We offer a wide-variety of personal emergency response and telehealth devices that can be used in the home-setting, and we provide 24/7 monitoring and click-to-chat support services to provide support, information, and educational materials to patients, providers, and payers.

I’d like to hear your thoughts on mobile health information. Is this something you’re doing or considering as a value-added service? Please share your questions and comments, and let’s all learn from each other.

Evolving Pharma Sales Models: The Customer is King

How pharmaceutical, biotechnology, and medical device products are sold is changing and it will continue to do so for the foreseeable future. There are many factors driving this change, and two of the most significant are healthcare reform changes and that healthcare providers are demanding meaningful interactions with company representatives. Life science companies are developing new sales models that aren’t solely a “sales pitch”. Rather, the interaction is “customer-centric” and based on meeting the customer’s needs and providing value.

Evolving your sales model to be focused on meeting customer needs is much more than just adapting your sales messages to address the latest concerns heard in the field. This is a fundamental mindset change, and life sciences companies have think about what it is they are offering and delivering. In the future our healthcare system will be focused on patient outcomes and cost. This environment requires the life science industry to provide programs that support treatments to improve patient outcomes, provide value, and decrease costs.

Patient adherence is an important driver in improving patient outcomes and decreasing future healthcare costs, but it is not the only one. In many disease-states and conditions there are health, wellness, and lifestyle factors that contribute to long-term improvement in outcomes and decreases in healthcare expenditures. There is an opportunity, and need, for life sciences companies to partner with patients, providers, and payers to address health, wellness, and lifestyle factors.

There are many programs that can be developed and implemented that will improve patient outcomes. To create meaningful programs patients can “stick to”, think about these areas…

* Understand the barriers patients face in remaining adherent and compliant with therapy.

* Plan programs that support patients on their treatment journey, and help them adhere to treatment.

* Develop patient support programs that are a resource and guide for patients during their treatment journey.

I encourage you to think holistically about the challenges of patients, providers, and payers and design programs to meet these broad needs. As life science companies look to evolve their sales models to meet customers’ needs and provide meaningful interactions, the need for programs that support patients, providers, and payers will increase. Provide solutions, through your product and its related services, to manage or overcome the broad healthcare challenges your customers face.

There are many options for providing programs that enhance patient outcomes. As a pharmaceutical call center, we provide as needed call-in support for patients, caregivers, and healthcare providers to answer questions about a product and its side effects, enroll patients in a support program, connect patients with healthcare providers in their local area, and connect patients with co-pay assistance resources. Our experiences show that within 6 months of implementing a patient support program patient adherence increases 10% to 15%. Patient adherence to treatment decreases future healthcare costs related to treating complications from earlier non-adherence.

There was an interesting article recently published on Pharmaceutical Executive on-line that looks at the evolving nature of pharmaceutical sales forces as they evolve to a more “customer-centric” approach. If you are interested in learning more about one model for moving in this direction you can access the article here.

I’d like to hear from you. Are you adding programs to support patients as a part of your marketing and sales efforts? If you are, what kinds of initiatives and programs are you planning? Please join the conversation and share your thoughts and challenges. We can all learn from each other. Alternatively, if you have specific needs you’d like to discuss with me you can reach me directly at louis.shapiro@tunstallamac.com.

View full blog

View website for Tunstall AMAC Life Sciences  

Budget Planning: Creating Impact with Less Investment

Declining Patient Adherence is a Key Concern

It’s August and many of us are in the midst of budget planning season. We are all aware of the reality facing the life sciences industry—more drugs coming off patent leading to less revenue and increasing costs to develop new treatments. Now more than ever, life science companies are faced with the need to do more with less. For marketers this means maximizing the impact of each program.

My advice to clients is to initially focus on programs that are quick to impact such as patient retention, attracting appropriate patients to consider your product, and maximizing the efficiency of your sales force. Below are a few specific programs you should consider.

Begin with patient compliance and adherence to therapy. It has been reported that compliance to therapy averages between 50% and 65%. There is a tremendous opportunity to increase the number of patients that adhere to treatment. The added benefit is it is much less expensive to keep patients on treatment than it is to attract new patients. To increase patient compliance and adherence consider…

* Patient support programs—these programs focus on patients and help them meet their needs and overcome their challenges. As a pharmaceutical call center we have healthcare-trained representatives available 24/7 and 365 days/year to answer patient questions and provide materials about their condition, treatment, side effects, and even can direct them to reimbursement assistance programs if they need it.

Support DTC marketing efforts and make it easy for patients to act on the awareness built by the advertising campaigns. To increase the effectiveness of your DTC marketing programs consider…

* Adding pharmaceutical call center support to handle inquiries from your advertising campaigns. A pharmaceutical call center we can answer patient questions, and can also provide referrals to physicians and specialists located near the patient’s home or work.

* Including click-to-chat support through websites. Make it easy for patients to ask questions and receive quick replies when they are interacting with one of your websites. Click-to-chat functionality provides real-time interactions, which is a tremendous advantage. As a pharmaceutical call center we can provide healthcare-trained representatives to answer patient questions submitted through websites and can provide links to materials and referrals to physicians and specialists too.

Maximize your field-based sales force so they focus on providing value to healthcare providers. To increase the effectiveness of your field-force consider…

* Partnering with a pharmaceutical call center to drive action with healthcare providers such as booking appointments for sales representatives and enrolling sites in a study or patient support program.

* Shifting administrative tasks such as replenishing samples and overseeing distribution and fulfillment. Our call center representatives reach out to healthcare providers on a regular basis to ensure they have adequate supplies of samples and materials. Additionally, we can oversee database updates and targeting and cleansing activities too.

The challenge to do more with less will continue for the foreseeable future. The formula for success is to create the most value from our investments. There are many opportunities to create value, and I have shared a few of my thoughts on how a pharmaceutical call center partner can help. I’d like to hear from you. What are your challenges? How are you creating more value for your investment?

View full blog

View website for Tunstall AMAC Life Sciences 

Free Podcast: Improve Patient Adherence with Patient Support Programs

 In the latest podcast, I share my thoughts on improving patient adherence through patient support programs. Specifically, I discuss how patient support programs contribute to higher patient compliance rates, better patient health, lower healthcare expenses, and improved patient retention.

If you would like to listen to this podcast, please click to download it now. After you listen to the podcast, let me know what you think of it—is it helpful? Are you currently providing patient support programs? If so, please share your experiences and insights on these programs. This area is evolving quickly, and we can all learn from one another.

We also recently published a free white paper titled “Increase Patient Adherence and Do More with Less”. We encourage you to download this companion piece to the podcast.

View Full Blog 

View website for Tunstall AMAC Life Sciences 

Fact: Healthcare Is Changing

Efforts to reform healthcare are moving forward as it is clear that as a nation we must decrease healthcare costs. Right now there are more questions than answers about the impact of the Affordable Care Act (ACA) that the US Supreme Court recently upheld. One thing is clear—the US healthcare system is changing. Below are my thoughts on three key areas the life science industry must prepare for.

Articulate the value of your product.

Conventional end points of safety, efficacy, and quality of life are no longer sufficient. Be prepared to demonstrate cost-effectiveness or cost-avoidance.

Implementation tips...

1) Work collaboratively with your colleagues in marketing, managed care marketing, pharmacoeconomics, clinical affairs, medical affairs, and regulatory to understand the data that is desired by various stakeholders when they are determining if a product is valuable or not. Develop plans to obtain the needed data.

2) Determine which patients are most likely to benefit from your product. Communicate to healthcare providers the patients that are most likely to benefit from treatment. Additionally, assist with screening and referring appropriate patients to local physicians or study sites.

Plan for government rebate plans and pricing controls.

If your treatment is expensive, be prepared for limitations on its use compared to less expensive alternatives.

Implementation tips...

1) Adjust your forecasts

2) Begin working on how to articulate the value of your product (see above for insights)

Provide programs that enhance outcomes for individual patients.

Shift your focus to taking care of patients and improving their outcomes. Patients will stay on treatment and future healthcare expenses resulting from patient non-adherence will decrease.

Implementation tips...

1) Plan and implement programs that support patients on their treatment journey.

2) Understand the barriers patients face in remaining adherent and compliant with therapy.

3) Develop and implement patient support programs that are a resource and guide for patients during their treatment journey. This can include offering access to healthcare-trained representatives for questions or providing educational materials to help patients continue with treatment.

There are many ways you can articulate the value of your product. Additionally there are many options for providing programs that enhance patient outcomes. As a pharmaceutical call center, we provide as needed call-in support for patients, caregivers, and healthcare providers to answer questions about a product and its side effects, enroll patients in a support program, connect patients with healthcare providers in their local area, and connect patients with co-pay assistance resources. Our experiences show that within 6 months of implementing a patient support program patient adherence increases 10% to 15%. Patient adherence to treatment decreases future healthcare costs related to treating complications from earlier non-adherence.

The June 2012 issue of PharmaVOICE magazine has an article on healthcare reform and the potential impacts of it on the life science industry. If you are interested in additional perspectives on the impact of healthcare reform you can access the article here.

I’d like to hear from you. How are you preparing for the impact of the ACA? What areas have you identified as opportunities? What kinds of initiatives and programs are you planning? Please join the conversation and share your thoughts, challenges, and questions on the ACA implementation. We can all learn from each other.

View Full Blog 

View website for Tunstall AMAC Life Sciences 

White Paper - Do More with Less—Invest in Patient and Caregiver Support Programs

A successful model

Patient adherence is a hot issue for all players (ie, payers, healthcare providers, life science companies, and patients) in the healthcare industry. Unfortunately all chronic conditions have low rates of patient compliance to therapy with the average being between 50% and 65%. Patient noncompliance is a significant problem, and for the life science industry it is particularly problematic as patients that start a therapy are not likely to continue it for the needed duration. This has a significant financial impact for life science companies as it costs six times more to attract new patients than it does to retain existing ones.

We have seen adherence rates increase by 10% to 15% after a patient and caregiver support program is implemented and maintained for one year. Increasing patient adherence is a win:win:win situation. Patients gain better health and enhanced quality of life, payers decrease expenses treating future healthcare issues that arise from non-compliance, and life science companies retain patients on therapy.

In our patient and caregiver support programs we have seen significant demand from patients for personalized experiences and information. The days of developing and disseminating materials for the masses are ending. Rather, patients want information specific to them, their condition, and needs.

Opportunities for providing patients with personalized information abound, and I have recently published a white paper on how to develop successful patient and caregiver support programs, as well as emerging trends being used to deliver customized and personalized experiences for patients. Patient and caregiver support programs can help life science companies retain patients on treatment and create real value for patients, healthcare providers, and payers.

If you’d like a copy of the white paper titled “Increase Patient Adherence and Do More with Less,” please click to download it. Please let me know what you think of this latest white paper—is it helpful or not? Also, let me know what areas you’d like to see more information and recommendations on.

View Full Blog  


View website for Tunstall AMAC Life Sciences

ASCO: Celebrate Successes and Prepare to Support Patients in the Future

The annual scientific meeting for the American Society of Clinical Oncology (ASCO) starts this weekend in Chicago. This meeting is the premier scientific meeting for new clinical data in oncology. Reflecting on this important meeting I’m reminded of the significant advances that have been made in the last 15 years in treating cancer. Several trends fill me with hope for the future, including…

1) Increasing use of oral therapies
2) Molecularly targeted therapies offer decreased side effects versus traditional chemotherapy
3) The possibility that cancer, in many cases, can be treated as a chronic condition with an emphasis on on-going therapy

Cancer treatment is certainly much more effective, manageable, and tolerable than it was 15 years ago. While there are many advances in oncology treatment to celebrate, significant challenges remain including…  

* Patient adherence to treatment—As more oral treatments are used for treating cancer, patients and their caregivers take on a greater role for ensuring treatments are taken regularly and at prescribed doses. With treatments administered in a physician’s office or medical center the nurses see patients regularly and ensure treatments are administered as prescribed and at appropriate times. 

* Changing needs of patients and caregivers—As patients and caregivers take on more responsibility for administering treatments, they are also taking on more responsibility for monitoring and managing side effects to treatment. This can be a frightening responsibility for caregivers and more can be done to support them in this role.  

* Increased costs for treatment—On average targeted therapies cost significantly more than traditional chemotherapeutic agents. The increased cost is an issue for all stakeholders involved in oncology treatment including patients, caregivers, healthcare providers, payers, and life science companies. Patient co-pay and financial assistance programs are critical in helping many patients pay for their treatment.

For life science companies these challenges are significant, and they are also opportunities to engage with patients, caregivers, and healthcare providers. To begin, ensure you…  

* Understand the patient’s treatment journey, and in particular, the barriers they face in remaining adherent and compliant with treatment 

* Develop and implement comprehensive patient support programs that are a resource and guide for patient’s during their treatment journey  

* Inform and educate healthcare providers on the details of patient and caregiver support programs

As a pharmaceutical call center, we provide as-needed call-in support for patients, caregivers, and healthcare providers to answer questions about a product and its side effects, enroll patients in a support program, and connect patients with co-pay assistance resources. Our Medical Advisory Board works with us to design programs focused on meeting the needs of patients, caregivers, and healthcare providers.

I’d like to hear from you. What challenges does your oncology product(s) face? Please join the conversation and share your thoughts, challenges and questions.

I’ll be in Chicago at the ASCO meeting. If you’ll be at ASCO, please send me an e-mail and we’ll schedule a time to get together. I always enjoy learning about the challenges you're facing.

View Full Blog

Keep it Simple: Focus on the Patient with Adherence Programs

Hi, I'm Moriah Weissman and I'm a Clinical Director at Tunstall AMAC. I work with Lou and our life science company clients to provide clinical insights for the development of patient, caregiver, and healthcare provider support and communication programs. Lou invited me to contribute to the blog, and I look forward to sharing insights and thoughts with you, as well as learning more about your challenges.

In working with our clients there is a lot of interest in life science companies about maintaining patients on a treatment. A number of articles and studies have been published about patient adherence, and I certainly believe patient adherence can be a driver in your business. In looking at many of the patient adherence articles that have been published two thoughts come to my mind…

1. Why do most patient adherence programs seem so complicated?
2. Patient adherence programs are expensive, time-consuming, and difficult to implement!

Many of the patient adherence articles quickly become lost in the data, in analysis paralysis, or in defining whether or not a program is truly patient adherence based solely on whether or not it’s driving “behavior change”.

Perhaps I have over simplified the definition of patient adherence. To me, patient adherence is keeping a patient on a specific treatment. There are many ways this can be done, and certainly I agree that it’s important to embark on a discovery process that helps you to understand the patient journey and a patient’s desire to manage their condition. Without this it’s easy to develop a program that doesn’t drive the right actions. In fact an earlier blog post by Lou Shapiro provided suggestions for understanding the patient journey and resources for understanding a patient’s desire to manage their condition.

I believe two critical success factors for effective patient adherence programs are…

1. Develop meaningful programs that engage patients.
2. Collect feedback and data so the program can be continuously improved.

We offer four straightforward solutions to help our clients build effective patient adherence programs. These include…

1. Our focus is the patient. Start with the patient and keep them, and their needs, at the center of your solution.

2. Our AMAC Medical Advisory Board. We have relationships with healthcare providers in a number of therapeutic areas. We engage these experts to help us understand a particular disease-state/condition, current care delivery models as well as patient needs and challenges. We then work with our Medical Advisory Board to develop custom healthcare communication solutions that meet patients’ needs.

3. Our clinical program directors. They have advanced life science degrees in nursing and pharmacy. We tap into their clinical expertise to understand the patient journey and barriers to treatment as well.

4. Our pharmaceutical call center operators. They talk with healthcare providers and their offices, as well as patients and caregivers each day. They hear first-hand about the challenges patients have in managing their condition. Whether the challenges have to do with side effects, dosing, or cost, our call center operators can describe in detail what the obstacles are that patients face.

To build an effective program we take these insights and evaluate them against the product’s goals and needs. Next, we start putting together solutions that we, as a pharmaceutical call center, can provide. We also work with our clients to integrate other services, such as customized direct mail fulfillment, as appropriate.

Of course, I’ve simplified our development process for the sake of keeping this post brief. And my point is this: patient adherence programs are not rocket science. They can be straightforward and still be effective. I’m willing to bet that if you keep the patient, and their needs, at the center of your solution it will be a success.

Now, I want to hear from you. Do you agree, or do you think my oversimplified approach is wrong? Join the conversation and share your thoughts, challenges and questions.

View Full Blog  

View website for Tunstall AMAC Life Sciences 

Essential Elements for Impactful Patient Adherence Programs

Keys to Patient Adherence

 My last few posts have focused on the opportunities increased patient adherence offers. I hope I have provided convincing information and that you are committed to either developing a patient adherence program (if one does not exist) or to bolstering an existing patient adherence program.

Here are my top 7 critical success factors for implementing successful patient adherence programs:

1. Elevate patient adherence to be a driver in your business. Patient adherence rates are low (on average are around 50% to 65%) and opportunities abound to increase patient adherence and retain patients on therapy.

2. Establish clear goals for your patient adherence program. Patient adherence is part of a product’s value proposition. Ideally, consider patient adherence early in product development. If your product is on the market that’s OK. It’s never too late to support patient adherence.

3. Appoint an owner. To ensure success there needs to be someone driving the program and accountable for its results whether in house or as an outsourced program manager.

4. Understand the patient journey. Patient adherence is a complex issue and requires a thorough understanding of the root causes of discontinuing treatment. Develop a holistic view of the behaviors and challenges in treating the condition.

5. Segment patients based on their desire to manage their condition. Use the Patient Activation Meter (PAM) to help you identify the “right” patients. Next, focus on these patients and their needs. Spend your time and resources reaching out to the “right” patients. For more information on the PAM, please review an earlier blog post on this topic.

6. Engage patients through enriching experiences. Understanding the patient journey, and those patients that want help, allows your program to provide more effective and meaningful materials and support services. Meaningful engagement drives compliance and adherence.

7. Collect data and continuously improve the program. Analyze the data and act on the learning’s to improve the program. Patient adherence programs have the potential to provide win:win solutions for patients and manufacturers.

This list was developed based on my experiences working with AMAC to develop effective communications and patient adherence programs for our clients. AMAC offers a wide-variety of patient monitoring devices used in the home setting, and provides 24/7 call center and click-to-chat support services to provide information and educational materials to patients, providers, and payers.

Do you agree with these critical success factors? Do you have additional ones to share? Join the conversation and share your questions, challenges, and best practices.

- Lou Shapiro

View Blog 

View website for Tunstall AMAC Life Sciences 

Trends in Patient Adherence Programs: Personalized Information and Experiences

The search for valuable information is a common theme for healthcare providers and patients. In the last several blog posts I have focused on healthcare providers, and in this post I’ll shift to patients. Patients are looking for information to help them manage their health conditions, and the pharmaceutical, biotechnology, and medical device industries have the knowledge to be a trusted source of information. Patients are using online resources and networks for healthcare education and support. This is driving the demand for personalized materials and educational experiences. Patients no longer will settle for materials developed for the masses. Rather, they demand information that is specific to them, their condition, and their needs.

How do you deliver this customized information? Options abound, and what is most important is that manufacturers recognize their role in developing effective patient adherence programs. Some of the newest trends being used in patient adherence programs include:

• On-demand live call center support

• Online resources through websites and social networking sites

• Click-to-chat support through websites

• Mobile sites and applications

• Patient monitoring devices

The heart of a successful patient adherence programs is communication. And pharmaceutical call centers can be an invaluable resource to provide 24/7 access to live operators to answer questions, send educational materials, and follow-up with patients to remind them about appointment and prescription refills. For more information on selecting a pharmaceutical call center partner, please see this earlier blog post.

Online resources play an important role in effective patient adherence programs. Online resources such as websites, click-to-chat support, and social networking sites are ideally suited to provide individualized and targeted information based on patient characteristics. However, many pharmaceutical, biotechnology, and medical device companies are reluctant to move quickly and deeply into providing online resources given the lack of regulatory guidance, concerns about patient privacy and well-being, and the cost of implementing these programs.

Additionally, mobile applications are being used more often to access information, communicate alerts about a particular product, and provide reminders to patients about appointments and refills.

There are numerous patient monitoring devices available for use in the home setting. These monitoring devices provide physicians and healthcare providers with timely information on a patient’s condition. This information allows physicians and healthcare providers to make immediate changes, if necessary. Let’s think about this for a minute. The technology exists for physicians and their healthcare staff to monitor the blood glucose levels, heart rate, blood pressure, oxygen saturation, and temperature of patients in their homes, and to make changes that could have a profound impact on their health today and in the future.

The future of patient adherence is centered on empowering patients to take an active role in managing their conditions. Patients need information, support, and guidance from their physicians and healthcare providers. This can be an overwhelming task for physicians and healthcare providers given the demands on their time. Opportunities exist for pharmaceutical, biotechnology, and medical device companies to provide information and educational materials.

At American Medical Alert Company (AMAC), we are in a unique position to support patient adherence programs. AMAC offers a wide-range of patient monitoring devices that can be used in the home setting, and provides 24/7 call center and click-to-chat support options to share information and educational materials with patients, providers, and payers. We have helped numerous clients design and build successful patient adherence programs.

Please share your thoughts on the emerging trends in patient adherence programs. Are you considering, or have you tried any of these new tools? If so, what are the factors driving your decision to use a new tool or not? Join the conversation and share your questions, challenges, and best practices.

Visit our website for more information on patient adherence and other topics.

View Blog  

View website for Tunstall AMAC Life Sciences 

Patient Adherence: Focus on the Patient

Happy New Year! I don’t know about you, but I had great holidays and I’m charged up and eager to build on the new opportunities 2012 will surely bring.

In my blog post before the holiday break I recommended that marketers in pharmaceutical, biotechnology, and medical device companies think about patient adherence as a significant driver for their business. I feel strongly that well-developed patient adherence programs provide win-win-win solutions for all stakeholders.

Valuable patient adherence programs focus on the patient and meeting their needs. As with most programs, the first step is to think strategically about patient adherence. Ideally, this would be early in the development of your product. However, your product may be well into clinical development or post-launch, and it isn’t too late to implement a patient adherence program. I’d ask you to think of these key factors to determine if patient adherence could help your product:

• Treats a chronic conditions
• Dosing or administration challenges
• Low rates of patient retention
• Good patent life (ie, 5 years or more)

I think of patient adherence as a part of the product’s value proposition. To design successful patient adherence programs, focus on the patient and understand their behaviors and challenges in the disease-state your product is used. Understand what behaviors they exhibit and why. Once you have this understanding you can develop targeted and personalized approaches to support patients. Ultimately, provide targeted resources online, via mobile devices, and in print. This targeted approach builds a sense of value, commitment, and trust with patients. Additionally, if patients are able to overcome challenges they will stay on therapy, which provides them with a greater quality of life, and decreases healthcare costs.

Are you wondering where to begin? We start by mapping the patient journey. Despite individual behaviors and attitudes, patients generally follow a typical path in managing their condition.

Judith H. Hibbard and James J. Cunningham have developed the Patient Activation Meter (PAM). This is the first instrument that measures the skills, knowledge, beliefs and behaviors that combine to create an activated patient. It indicates that patients progress through four (4) stages as they become activated. PAM can be used to assess how well interventions work. The authors of the PAM have measured and identified characteristics for patient activation based on population and health status characteristics. The Center for Studying Healthcare System Change has published this information on their website. This is a good resource for gathering information on patient activation in various disease states.

The PAM tool can help to identify the key areas where support is needed and identify patients receptive to help and support. This information ensures time and money are spent on patients that are receptive to help. The goal is to focus on the patient and understand their journey so you can develop a patient adherence program that uniquely supports their needs.

At American Medical Alert Company (AMAC), we are in a unique position to support patient adherence programs. AMAC offers a wide-range of patient monitoring devices (many of them are used in the home setting), and provides 24/7 communication services to share information and educational materials with patients, providers, and payers.

Share your experiences with patient adherence programs. What key insights have you learned along the way? What tools have you used to understand the journey patients are taking in treating their condition? Have you been able to leverage this knowledge to develop more impactful and effective materials and patient adherence programs?

View Blog  

View website for Tunstall AMAC Life Sciences 

Patient Adherence: Focus on the Patient

This post has been relocated to:
http://phonescreenblog.blogspot.com/2012/01/patient-adherence-focus-on-patient.html

View Blog 

Patient Adherence: The Next Significant Opportunity for Manufacturers

In previous blog posts I have discussed in general the changes happening in the pharmaceutical and healthcare industries. The general theme of “do more with less” is strong and continues to grow stronger. In previous blog posts I have discussed the opportunities with complementary sales channels such as tele-detailing, e-detailing, and web advertising to physicians. Another significant opportunity for the pharmaceutical and healthcare industries is increasing patient adherence to treatment.

All chronic conditions have high rates of patient noncompliance. It is commonly reported that patient compliance to therapy averages around 50 to 65%. According to a recent report by Capgemini Consulting, titled “Patient Adherence: The Next Frontier in Patient Care,” only 69% of patients fill their first prescription. Only 43% of patients that start a prescription therapy are continuing that therapy 6 months later. This has a profound impact on future healthcare costs as these patients typically have additional healthcare issues in the future related to earlier non-compliance. Supporting patient adherence is a win:win:win situation—patients gain with better health and quality of life, payers decrease their expenses treating healthcare issues that arise from non-compliance, and companies retain patients on their products.

Patient noncompliance is a significant problem for the industry. Think of the benefit if companies could increase retention to 65% or 75% of patients continuing therapy at 1 year (rather than 6 months as Capgemini found).

As I looked at the Capgemini Consulting report, I kept thinking about the expenses pharmaceutical, biotechnology, and medical device companies spend to acquire new patients, and the sales to be gained by retaining more patients on treatment. It is a commonly accepted principle in many industries that it is cheaper to retain customers (patients in this case) than it is to acquire new ones. This principle needs to be more of an emphasis in our industry. Pharmaceutical, biotechnology, and medical device companies must take action to develop and implement successful patient adherence programs. Not doing this is like leaving money on the table, and that is NEVER something you want to do.

The first step is to think strategically about patient adherence early in the development of your product. Think of this as part of the product’s value proposition. At PhoneScreen we’ve worked with a number of clients to develop and implement their patient adherence programs through 24/7 live operator support to answer questions, send requested educational materials, and call to remind patients about appointments and refills. There are several essential elements to an effective patient adherence program, and we’ll discuss these in a future blog post.

For now, I’d like to challenge marketers in pharmaceutical, biotechnology, and medical device companies to think about patient adherence as a significant driver for your business. In my first post in 2012 I’ll share my thoughts on how to develop the strategic direction for your patient adherence program. In early-2012, we’ll explore current trends in patient adherence programs and essential elements for successful patient adherence programs.

Do you currently have a patient adherence program for your product? If so, how successful is it at retaining patients? If you haven’t implemented a patient adherence program, why haven’t you? I’d love to hear about the hurdles or challenges you face in setting up/maintaining your patient adherence program.

Until 2012, best wishes for very Happy Holidays and a healthy and prosperous New Year!


View Blog

View website for Tunstall AMAC Life Sciences